The regulatory influence of the parathyroid hormone (PTH) is exerted on bone, which serves as a vital reservoir of calcium within the body. While various aspects of bone growth, turnover, and mechanisms operate independently of gonadal hormones, a crucial role is assumed by sex steroids, particularly estrogen, in maintaining bone equilibrium in adults. In order to unravel the underlying mechanisms of bone remodeling mediated by PTH, a distinguished mathematical model of this intricate process is presented. Subsequently, the temporal effects of Plasma PTH and PTH external dosages are investigated using the proposed mathematical model. Among the limited repertoire of approved and accessible anabolic treatments for severe osteoporosis, daily injections of PTH stand out. This pharmaceutical marvel possesses a unique dual action, capable of acting either anabolically or catabolically, contingent upon the mode of administration. The study aims to accurately predict osteogenic responses to introduced and endogenous PTH, incorporating factors such as TGF-β, RANKL, and bisphosphonates in osteoblast–osteoclast signaling, as well as considering PTH’s influence on the gland and the regulatory roles of Runx2, pCREB, and Bcl2 in osteoblast apoptosis and bone volume effects. Through diverse methods including illustrative depictions, numerical simulations, sensitivity analysis, and stability analysis, this work seeks to comprehend how PTH therapy impacts bone volume, enhancing its therapeutic relevance.